Hematology Drugs Global Market To Grow At Rate Of 10% Through 2025

Hematology Drugs Global Market Report 2021 - COVID-19 Impact And Recovery

Hematology Drugs Market Report 2021 – COVID-19 Impact And Recovery

The Business Research Company’s Hematology Drugs Global Market Report 2021 – COVID-19 Impact And Recovery

LONDON, GREATER LONDON , UK, November 17, 2021 /EINPresswire.com/ — According to the new market research report ‘Hematology Drugs Global Market Report 2021: COVID-19 Impact And Recovery’ published by The Business Research Company, the hematology drugs market is expected to grow from $78.83 billion in 2020 to $82.57 billion in 2021 at a compound annual growth rate (CAGR) of 4.7%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $119.92 billion in 2025 at a CAGR of 10%. The hematology drugs market growth is aided by stable economic growth forecasted in many developed and developing countries.

Request For A Sample For The Global Hematology Drugs Market Report:

The hematology drugs market consists of sales of hematology drugs and related services by entities (organizations, sole traders and partnerships) that produce hematology drugs to treat diseases such as genetic disorders, anemia, and other related diseases. This industry includes establishments that produce blood products such as red blood cells, white blood cells, platelets, and fresh frozen plasma. It also consists of establishments which produce of anemia and other blood disorder drugs to treat anemia, hemophilia and blood clots.

Trends In The Global Hematology Drugs Market
Tranexamic acid is increasingly being used to prevent postpartum hemorrhage (blood loss of over 500 ml or 1,000 ml within 24 hours of childbirth) due to its low price and wide availability. Tranexamic acid is an antifibrinolytic drug that helps in reducing bleeding in surgical and trauma patients, including women with postpartum hemorrhage. According to the World Maternal Antifibrinolytic (WOMAN) trial conducted in April 2017, using tranexamic acid within three hours of childbirth lowered death from bleeding by 31% and reduced the need for laparotomy (emergency bleeding control surgery) by 36%. The trial included over 20,000 women from 193 hospitals in 21 countries.

Global Hematology Drugs Market Segments:
The global hematology drug market is further segmented:
By Type: Blood Products, Anemia And Other Blood Disorder Drugs
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others
By Route Of Administration: Oral, Parenteral, Others
By Drug Classification: Branded Drugs, Generic Drugs
By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs
By Geography: The global hematology market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, the Asia-Pacific hematology drugs market accounts for the largest share in the global hematology drugs market.

Read More On The Report For The Global Hematology Drugs Market At:

Hematology Drugs Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides hematology drugs global market overviews, analyzes and forecasts market size and growth for the global hematology drugs global market, hematology drugs global market share, hematology drugs market players, hematology drugs global market segments and geographies, hematology drugs market’s leading competitors’ revenues, profiles and market shares. The hematology drugs market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Read Hematology Drugs Global Market Report 2021 from The Business Research Company for information on the following:

Data Segmentations: Market Size, Global, By Region And By Country; Historic And Forecast Size, And Growth Rates For The World, 7 Regions And 12 Countries

Hematology Drugs Market Organizations Covered: Novo Nordisk A/S, Shire Plc, Bayer AG, Daiichi Sankyo Company, Biogen Inc.

Regions: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.

Countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

Interested to know more about The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

Get a quick glimpse of our services here: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Here is a list of reports from The Business Research Company similar to the Hematology Drugs Global Market Report 2021:

Hematology Diagnostic Devices And Equipment Global Market Report 2021: COVID-19 Impact And Recovery

Anemia And Other Blood Disorder Drugs Global Market Report 2021: COVID-19 Impact And Recovery

Alpha Mannosidosis Global Market Report 2021: COVID-19 Growth And Change

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email: info@tbrc.info
Follow us on LinkedIn: https://bit.ly/3b7850r
Follow us on Twitter: https://bit.ly/3b1rmjS
Check out our Blog: http://blog.tbrc.info/

Oliver Guirdham
The Business Research Company
+44 20 7193 0708
Visit us on social media:

Leave a Reply

Your email address will not be published. Required fields are marked *